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Abstract 
Purpose: To investigate the in vitro anti-proliferative effect and mechanism of action of Moringa oleifera 
Lam. leaf extract on human colon carcinoma HCT116 cell line.  
Methods: M. oleifera leaves were extracted with methanol. It was fractionated by Sephadex LH-20 
column chromatography. Several fractions were identified by thin layer chromatography (TLC), proton 
nuclear magnetic resonance (1H NMR) and mass spectrometry (MS). The growth inhibitory activity and 
mechanism of action of the extracts in HCT116 colon cancer cells were investigated by 3-(4, 5-
dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay and Western blotting. 
Results: Successive fractions from M. oleifera leaf crude extracts by column chromatography were 
combined into four pooled batches (MOL1 - MOL4) according to their absorbance at 260 nm and TLC 
pattern. MOL2 and MOL3 contain astragalin and isoquercetin, respectively. The results from MTT assay 
indicated that cell proliferation was significantly (p < 0.05) inhibited in a concentration-dependent 
fashion, especially by MOL2, MOL3 and MOL4. MOL2 and MOL3 exhibited a stronger cell growth 
inhibition than their major ingredients. The anti-proliferative activity of MOL2 - MOL4 in HCT116 colon 
cancer cells was mediated by downregulation of ERK1/2 phosphorylation.  
Conclusion: M. oleifera leaf extract has a strong anti-proliferative activity which is exerted by 
decreasing ERK1/2 phosphorylation. Thus, the extract has a potential for use in cancer 
chemoprevention. 
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Cancer is one of the leading diseases that results 
in hundreds of thousand deaths among Thais [1-
3]. Many of the naturally derived anti-cancer 
drugs successfully became current drugs such 
as placitaxel, vincristine, and vinblastine. Several 
wild edible plant species in Thailand have played 
a prominent role in traditional medicine [4,5]. 
Moringa oleifera Lam. (M. oleifera) is one of the 
most common plant found in Southeast Asia that 
has been widely used [6]. It is also a valuable 
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plant because it is rich in vitamins, protein, 
carbohydrate, fatty acid, fiber and phytochemical 
components. The phytochemical components 
present in M. oleifera such as glycosides, 
alkaloids, flavonoids and phenolics are thought to 
have anti-oxidant and anti-cancer effects [7]. 
Each part of M. oleifera showed different effects 
on cancer cells [6,8-10]. Moringa root extracts 
inhibit epithelial ovarian cancer growth [11]. 
Extracts of M. oleifera leaves have been found to 
elicit anti-oxidant, anti-inflammatory, anti-
bacterial and anti-fungal activities [12,13]. 
Moreover, M. oleifera leaf extracts inhibit human 
epidermal carcinoma (KB) cell growth analyzed 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyte-
trazolium bromide (MTT) assay [14]. 
 
Recently, astragalin, isoquercetin and 
cryptochlorogenic acid were discovered to be 
major active components in M. oleifera leaf 
extract [15].  Both astragalin and isoquercetin 
have been shown to possess anti-oxidant and 
anti-inflammatory activities [16,17]. Isoquercetin 
has been studied and found as a major bioactive 
component in St. John’s wort or Klamathweed 
(Hypericum perforatum L.) [18]. Furthermore, 
isoquercetin and astragalin are present in 
vegetables and fruits such as broccoli, onions, 
cherries, apples [19]. 
 
The major cellular functions known to be 
mediated by mitogen-activated protein kinases 
(MAPKs) are cell differentiation and 
transformation, cell proliferation, cell death and 
survival. MAPK proteins are serine-threonine 
kinases that include extracellular signal-regulated 
kinase (ERK), p38, and c-Jun NH2-terminal 
kinase. The PI3K/AKT and RAS/RAF/MEK/ERK 
signaling pathways are frequently mutationally 
activated in human cancer.  AKT and ERK 
signaling pathways have been shown to 
coregulate several proteins promoting cancer cell 
survival and tumor growth [20]. Thus, the direct 
inhibition of AKT and ERK signaling pathways 
may provide a potential strategy for cancer 
therapy. 
 
A previous study showed that bioactive fractions 
from column chromatography separation of M. 
oleifera leaf extract exhibit apoptotic induction 
activity in HCT 116 colon cancer cells [21]. 
However, the bioactive compounds from M. 
oleifera leaves have not been clarified.  
 
The present investigation was undertaken to 
identify the phytochemical compounds from the 
bioactive fractions and to elucidate the 





Plant material and extraction 
 
Fresh M. oleifera Lam. leaves were collected 
during January 2012 - December 2013 from 
Amphoe Mueng, Nakhon Pathom, Thailand. 
Leaves were cleaned and subsequently dried at 
50-60 °C for 2 - 3 days. The dried leaves were 
blended by homogenization and extracted in 100 
% methanol for 3 days using a Soxhlet extractor. 
Alcohol solvent was completely removed from 
total extraction solution by using an evaporator. 
The crude extracts were kept in a light protected 
glass ware at < 4 °C until used.   
 
Column chromatography on Sephadex LH-20 
 
The dried crude extract of M. oleifera leaves was 
dissolved in 70 % (v/v) ethanol at 1 mg/mL and 
then filtered with 0.45 µm filter membranes 
(Merck Millipore, Bedford, MA, USA) immediately 
before use. The fractionation of crude extract 
was conducted by size exclusion 
chromatography as described previously [21]. 
Briefly, the extract was separated into fractions 
with 2.5 x 37.5 cm glass chromatography column 
(Bio-Rad Laboratories, Richmond, CA, USA) 
filled with expanded Sephadex LH-20 gel 
particles (10 - 25 µm; GE Healthcare, Waukesha, 
WI, USA) in 70 % (v/v) ethanol. The column was 
eluted with 70 % (v/v) ethanol. Collected fraction 
of 5 mL each was monitored by SmartSpecTM 
3000 spectrophotometer (λmax = 260 nm; Bio-Rad 
Laboratories, Richmond, CA, USA). Based on 
spectral readings, four pooled, combined, 
fractions (pf1-pf4) were collected. The four 
combined fractions were evaporated and freeze-
dried. Then, they were stored under refrigeration 
(-20 °C) and in a dark container.   
 
General procedure   
 
Optical rotations were measured with a 
JASCOP-1020 polarimeter (Tokyo, Japan). MS 
was measured on a JEOL spectrometer (JEOL, 
Tokyo, Japan). 1H NMR spectra were recorded 
on an ECA 600 spectrometer (JEOL, Tokyo, 
Japan) with deuterated solvent. Silica gel 
presqualene (PSQ) 100B or ODS Chromatorex 
(Fuji Sylisia, Kasugai, Japan) or Sephadex LH-20 
(GE Healthcare Waukesha, WI, USA) were used 
to carry out column chromatography. Thin layer 
chromatography (TLC) was done with glass pre-
coated ODS RP18 F254 plates (Merck, 
Darmstadt, Germany), developing with gradient 
methanol-H2O (40:60-80:20). Spots were 
detected using UV absorbance at 254 and 365 
nm and by spraying with 50 % H2SO4, then, the 
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plate was heated at 90 – 100 °C for at least 2 - 3 
min.   
 
Extraction and isolation   
 
Dried methanol extract of M. oleifera leaves was 
subjected to gel filtration on Sephadex LH-20 
with four pooled fractions (MOL1 - MOL4) 
collected. The bioactive fractions, MOL2 and 
MOL3 were resuspended in methanol and then 
subjected to octadecylsilyl (ODS) column with 
different mobile phases. MOL2 was eluted with a 
gradient mixture of 0 - 100 % methanol in H2O 
while the MOL3 was eluted with a gradient 
mixture of 30 - 100 % methanol in H2O. The 
dried MOL2 (40 mg) was eluted, collected and 
then analyzed by TLC, giving 38 fractions which 
were pooled into sixteen fractions (F1 - F16) 
based on the TLC patterns. Fraction F6, a yellow 
color spot on TLC plate, was concentrated using 
a rotary evaporator, yielding approximately 2.6 
mg of dried extract. F6 (2.6 mg) was further 
separated by gel filtration, Sephadex LH-20 
column, eluted with 80 % methanol and then 
analyzed by TLC. Based on the TLC patterns, 
the eluted subfractions were combined into 
thirteen subfractions (sf1 - sf13). The sf13 (0.9 
mg, compound A) was identified using 1H NMR 
and MS. The dried MOL3 (10 mg) was subjected 
to ODS column and eluted with similar 
procedures. The collected eluates were 
monitored using TLC to obtain 29 fractions (F1 - 
F29). F9 (1 mg, compound B) with a yellow color 
spot on TLC plate was identified using 1H NMR. 
The scheme of isolation is shown in Figure 1. 
The isolated pure compounds were identified by 
comparing their 1H NMR and MS with published 
data. 
 
Cell culture   
 
Human colorectal carcinoma cells (HCT 116) 
were kindly provided by collaborators. The cells 
were propagated in Dulbecco's Modified Eagle 
Medium (DMEM medium (Gibco, Carlsbad, CA, 
USA) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS), 100 U/mL penicillin, 
and 100 mg/mL streptomycin (Sigma). Cells 
were cultured in a humidified CO2 incubator at 37 
°C with 5 % CO2/air. Cells were assayed during 
the exponential phase of growth. 
 
Cell proliferation assay using tetrazolium salt 
(MTT) 
 
Cell proliferation was measured by MTT assay 
(Sigma-Aldrich). Briefly, cells (1.2 x 104 cells) 
were seeded in a 96-well flat-bottomed 




Figure 1: Separation scheme of M. oleifera leaf extract with gel filtration on Sephadex LH-20 after getting four 
pooled fractions 
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After 24 h, the media were removed and 
replaced with fresh complete medium. Cells were 
exposed to graded concentrations of test 
compounds (4 - 5 dilutions in triplicate; MOL1, 
MOL2, MOL3, MOL4, astragalin, and 
isoquercetin) for 24 and 48 h. 0.5 % DMSO-
treated cells was used as a negative control. 
Both astragalin and isoquercetin were obtained 
from Sigma-Aldrich. After the incubation period, 
each well was washed with phosphate-buffered 
saline (PBS) and replaced with 1 mg/mL MTT for 
4 h incubation. The resulting crystals produced 
from the MTT assay was dissolved in 100 µL of 
100 % DMSO and quantified at 550 nm using a 
microplate reader (Model No; AOPUS01 and 
A153601; A Packard bioscience company). The 
proportion of cell viability was calculated as 
previously described [14]. 
 
Cell extraction and western  blotting  
 
HCT116 cells were plated at a density of 1 x 105 
cells/mL onto a 6-well plate and incubated 
overnight. Varying concentrations of the M. 
oleifera pooled fractions were added into the 
cells for 48 h in triplicate cultures, compared with 
positive and negative controls.  After treatment 
with the samples, cells were washed with PBS, 
pH 7.4 and lysed with lysis buffer (with 1 mM 
Na3VO4 and 1 mM NaF inhibitor) on ice for 15 
min. Cell lysates were centrifuged at 13,000 g for 
10 min at 4 C, and protein concentrations of 
supernatants were estimated by Bradford protein 
assay. Equivalent amounts of total cellular 
proteins (5 - 25 g) were separated by 8 – 12 % 
SDS-PAGE. Each protein sample was added 
with sample loading buffer, boiled for 5 min and 
kept on ice immediately prior to electrophoresis 
through a 8 – 12 % SDS-PAGE at 110 volts for 
90 min. Proteins were then transferred onto 
PVDF membranes. The process was carried out 
for 1 h on ice. For immunodetection of the 
proteins, membranes were blocked in 5 % BSA 
in TBS-T buffer for 1 h. Probing of PVDF 
membranes with primary antibodies (pERK1/2 
polyclonal antibody #9101, Akt antibody #9272 or 
p38 MAPK antibody #9212) at 4 C overnight 
and horseradish peroxidase–conjugated 
secondary antibodies was performed, and 
signals were detected by enhanced 
chemiluminescence (ECL). All primary antibodies 
were purchased from Cell Signaling Technology. 
The chemiluminescence reagent was poured into 
the membrane and incubated for 1 - 5 min at 
room temperature and then excess 
chemiluminescence reagent was removed. The 
membrane was placed and covered with plastic 
wrap. The imaging film was put on top of the 
membrane for 5 - 10 min depending on the signal 
of the protein. The film was developed and 




All experimental measurements were tested in 
triplicate.  The results are expressed as mean ± 
standard deviation (SD).  Statistical analysis of 
data was evaluated using one-way analysis of 
variance (ANOVA). Significance level was set at 






Our preliminary results suggested that the crude 
extract from M. oleifera leaves shows inhibitory 
effect on cell growth in HCT 116 cells. The crude 
extracts from M. oleifera leaves were separated 
by size exclusion chromatography with 
Sephadex LH-20 as described previously [21]. 
The pooled fractions, MOL1 - MOL4, from the 
crude extract, were assessed against HCT 116 
colon cells for anti-proliferative activity in 24 h 
(Figure 2a, 2b) and 48 h (Figure 2c, 2d) using an 
MTT assay. After 24 and 48 h treatment with 
individual pooled fraction, it was shown that HCT 
116 cell growth was significantly inhibited in a 
concentration-dependent fashion, especially 
when treated with MOL2, MOL3, and MOL4. 
 
MOL2 and MOL3 from M. oleifera leaf extract 
 
The bioactive MOL2 and MOL3 were subjected 
to further isolation and identification analysis due 
to their drastic anti-proliferative activity, while 
MOL4 was not done because of recovery yield 
limit. Compound A from MOL2 and B from MOL3 
were got as a yellow amorphous powder. The 1H 
NMR spectra of A and B showed the 
characteristic signals of flavonoid glycosides. 
The molecular formula of A and B were indicated 
as C21H20O11 and C21H20O12, respectively by MS, 
which gave molecular ion peak at m/z 447 and 
463 [M-H] -. In addition to the mass of compound 
A and B 1H NMR spectra showed signals 
corresponding to a sugar moiety. Thus, the 
structure of A and B was determined as 
kaempferol 3-O-glucoside (astragalin) and 
quercetin 3-O-glucoside (isoquercetin), 
respectively.  
 
Astragalin: yellow amorphous powder, 
Molecular formula: C21H20O11. LC-MS: m/z 447 
[M-H]-. 1H NMR (600 MHz, CO3OD): δ ppm 7.92 
(d, J=8.72, 2H, H-2, 6), 6.75 (d, J=8.98, 2H, H-
3, 5), 6.21 (d, J=2.05, 1H, H-8), 6.03 (d, 2.05, 
1H, H-6), 5.08 (d, J=7.18, 1H, H-1 of Glc) [22]. 
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Figure 2: The anti-proliferative activity of each pooled fraction (MOL1-MOL4) on HCT116 cells at different 
concentrations for 24 h (a, b) and 48 h (c, d). Each value represents the mean ± SD of the triplicate of cultures, 
*p<0.05, significantly different from the negative control treated with 0.5 % of DMSO 
 
Table 1: Toxicity of each pooled fraction (MOL1 - MOL4) in HCT116 and NHF cells at 24 h and 48 h 
 
Sample 
IC40 (approx, g/mL) 
24 h 48 h 































 NA = not determined 
 
Isoquercetin: yellow amorphous powder, 
Molecular formula: C21H20O12, LC-MS: m/z 463 
[M-H]-. 1H NMR (600 MHz, CO3OD) δ ppm 7.70 
(d, J=2.31, 1H, H-2), 7.58 (dd, J=2.31, 8.46, 1H, 
H-6), 6.86 (d, J=8.46, 1H, H-5), 6.35 (d, J= 2.05, 
1H, H-8), 6.17 (d, J=2.05, 1H, H-6), 5.23 (d, 
J=7.69, 1H, H-1 of Glc).  
 
The peaks assigned in 1H NMR corresponded to 
previous studies [23,24]. 
 
Cell proliferation inhibitory effect 
 
In order to confirm that the anti-proliferative 
activity of  M. oleifera leaf extracts may come 
from their major compounds and may have a 
different effect on normal and cancer cells, the 
determination of cytotoxicity in normal human 
fibroblast (NHF) and HCT116 cells was done at 
24 and 48 h (Table 1). Because insufficient 
protein lysate obtained when IC50 was used in 
the cell, IC40 was used instead in Western blot 
analyses.  
 
The results showed that the cytotoxic effect of M. 
oleifera leaf extracts in HCT116 cells was higher 
than that in NHF cells. Although, MOL2 
contained astragalin, the cytotoxicity of MOL2 
was likely higher than its major component. In 
contrast, MOL3 contained isoquercetin, the 
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cytotoxicity of MOL3 was higher than its major 
component in 24 h of treatment but less than that 
in 48 h. Moreover, the cytotoxicity associated 
with M. oleifera leaf extracts in HCT116 was 
higher than that in the NHF normal cell line, 
demonstrating that normal cells are more 
resistant to the extract than cancer cells. 
 
To clarify the anti-proliferation mechanism of M. 
oleifera leaf extracts in 48 h treated HCT116 
cells, the protein expression of ERK, AKT, and 
p38 MAPK was further examined using the total 
protein from cells treated with various 
concentrations (two-fold of IC40, IC40 and one-half 
fold of IC40 value). Two anti-cancer drugs, 
adriamycin, and cisplatin, were used as positive 
control. Our results showed that HCT116 treated 
with M. oleifera leaf extracts resulted in 
drastically decreased p-ERK1/2 and little 
decreased AKT expression, but not p38 MAPK in 
a concentration dependent manner. Moreover, 
both adriamycin and cisplatin treatment showed 
a similar effect (Figure 3). 
 
 
Figure 3: Effect of each pooled fraction (MOL1-MOL4) in HCT116 cells at 48 h of treatment on AKT (upper 
panel), p38 MAPK (middle panel) and phospho-ERK1/2 (lower panel) expression using western blot and ImageJ® 
software analysis. Tubulin was used as loading control. Adriamycin (0.1 μg/mL) and cisplatin (125 μg/mL) were 
used as positive control 
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In Thailand, colon cancer is considered the most 
common cancer in men and the third in women 
[3]. The development and invasion process of 
cancers including colon cancer is correlated with 
PI3K/AKT and RAS/RAF/MEK/ERK pathways 
[20]. The concomitant activation of AKT and ERK 
pathway leads to enhanced cancer progression 
and metastasis. Chemoprevention by natural 
products to inhibit or prevent tumorigenesis is a 
new strategy for cancer control [25].  M. oleifera 
has long been used in Thai cuisine. Its leaves 
are a good source of nutrients and bioactive 
compounds [26]. There are many reports 
suggesting that M. oleifera leaves possess anti-
cancer properties with their anti-oxidant activity 
[8,9,11,14] or by down-regulating NF-ƙB [27].  
 
The present study focused on anti-proliferation 
activity and mechanism of action of four pooled 
fractions from M. oleifera leaf extract against 
HCT116 colon cancer cell line. In accordance 
with previous study, this method of extraction i.e. 
column chromatography is also effective in 
separation of major flavonoid glycosides, 
astragalin, and isoquercetin in M. oleifera leaves, 
[15]. Both astragalin and isoquercetin are shown 
to have antioxidant and anti-proliferative activities 
[28]. Therefore, the presence of astragalin and 
isoquercetin in M. oleifera leaf may be 
responsible for the promising property in 
chemoprevention. That was suggested by a 
significant suppression of HCT116 cell 
proliferation with the pooled fractions, especially 
MOL2-MOL4. 
 
As mentioned above, ERK and AKT pathways 
are important for proliferation and survival of 
cancer cells. Furthermore, there are few studies 
on the effect of M. oleifera leaf on these 
pathways in colorectal cancer. The results show 
that the phosphorylation of ERK1/2 was 
dramatically inhibited by M. oleifera leaf fractions, 
along with a small reduction in AKT expression, 
but not p38 MAPK.  
 
Taken together, the results show that M. oleifera 
leaf extract inhibits HCT116 cell proliferation 





Column chromatography has successfully been 
used for the separation of two flavonoid 
glycosides, astragalin, and isoquercetin, from 
bioactive fractions of M. oleifera leaf extracts. 
The bioactive fractions exhibit anti-proliferative 
activity against colon cancer cells that is different 
from standard compounds. A likely mechanism of 
action of the anti-proliferative activity is pERK1/2 
downregulation. Further studies are necessary to 
investigate the precise components as well as 
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